Physician profile
Michael Lucious Pomerantz
NPI 1356505705
$17,472.33
in general payments reported to CMS, 2019-2025
30 companies · $12K in 2025
The $12K reported for 2025 was more than what 93% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,230 · 2020: $156 · 2021: $360 · 2022: $492 · 2023: $1,176 · 2024: $2,079 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,838 · Food and Beverage: $5,016 · Travel and Lodging: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,837.50 |
| Food and Beverage | $5,015.87 |
| Travel and Lodging | $1,381.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,271.26 | 2021-2025 | Q-Fix, Spatial Frame, Fast-Fix |
| Acumed LLC | $1,881.50 | 2020-2025 | Acumed, Acumed, Innate Implant |
| Sonex Health, INC. | $1,207.79 | 2023-2025 | Sx-One Microknife |
| Depuy Synthes Sales INC. | $777.75 | 2019 | |
| Endo USA, INC. | $505.95 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $402.72 | 2020-2024 | Xiaflex |
| Stryker Corporation | $335.91 | 2021-2023 | Variax |
| Zimmer Biomet Holdings, INC. | $293.75 | 2021-2024 | Samples Biologics |
| Elevate Surgical Co | $190.51 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $141.50 | 2019-2025 | Exparel |
| Miach Orthopaedics, INC. | $136.72 | 2024 | |
| Breg, INC | $127.79 | 2022 | |
| Integra Lifesciences Corporation | $124.10 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tei Medical INC. | $122.62 | 2019 | |
| Nevro Corp. | $118.22 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $117.92 | 2019 | |
| Linvatec Corporation | $115.88 | 2019-2023 | Biobrace 23mm |
| Medical Device Business Services, INC. | $114.87 | 2019 | |
| Bioventus LLC | $86.28 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Avanos Medical | $77.13 | 2025 | Grpro 2.1 |
| Molnlycke Health Care US, LLC | $75.43 | 2024 | Avance, Mepilex Ag |
| Angiodynamics, INC. | $49.71 | 2024 | Angiovac |
| Boston Scientific Corporation | $40.04 | 2025 | Wavewriter Alpha Prime 16 |
| Impactortho, INC. | $33.08 | 2022 | |
| Fidia Pharma USA INC. | $26.12 | 2023 | Hymovis, Triluron |
| Medartis INC. | $23.02 | 2019 | |
| Abbott Laboratories | $21.23 | 2024 | Proclaim |
| Heron Therapeutics, INC. | $20.94 | 2021 | |
| Djo, LLC | $18.24 | 2019 | |
| Heraeus Medical, LLC. | $14.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pomerantz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.